Summary: A new study uncovered a stark biological link between traumatic brain injury (TBI) and long-term oncology outcomes. The investigation utilized nearly four decades of tracking data from the Traumatic Brain Injury Model Systems National Database, evaluating more than 20,000 civilian patients.
The analysis adjusted for extensive demographical variables and cancer risk factors. The team discovered that individuals with a history of TBI face a 1.75 times higher risk of dying from brain cancer compared to the general population. The risk spikes exponentially in specific sub-populations, with gunshot-induced TBIs demonstrating an over 14-fold surge in brain cancer mortality.
Key Facts
- Shifting from Incidence to Mortality: While historical, fragmented data hinted that moderate-to-severe head trauma might correlate with tumor development, this study is the first to systematically establish that TBI translates directly into worse survival outcomes and heightened brain cancer mortality at the population level.
- The 37-Year National Database Scale: Investigators parsed the TBI Model Systems National Database, compiling a massive longitudinal cohort of over 20,000 civilian patients who received inpatient neuro-rehabilitation across 20 specialized centers (including Spaulding Rehabilitation Hospital) between 1987 and 2024.
- The Gunshot Wound Risk Spike: Subgroup analyses by injury mechanism unmasked an alarming risk escalation: individuals whose traumatic brain injuries were caused by gunshot wounds were over 14 times more likely to die from brain cancer than demographically matched controls.
- The Mild Complicated TBI Vulnerability: The study revealed that even patients diagnosed with “mild but complicated” TBIs, head injuries that display intracranial abnormalities like localized bleeding on neuroimaging, exhibited a nearly 4-fold increase in brain cancer mortality risk.
- The Inflammatory Malignancy Hypothesis: Neuroscientists suspect the underlying driver is rooted in the chronic, long-term biological cascade triggered by trauma. The initial mechanical impact unleashes persistent neural inflammation and metabolic dysregulation, creating a biological microenvironment that may inadvertently fuel oncogenesis (tumor formation).
- Moving Past Acute Care Models: These findings reinforce a critical paradigm shift in medicine: a traumatic brain injury is not merely an isolated, acute surgical event. It is a chronic health condition with progressive neurological and oncological consequences that require lifetime surveillance.
- Future Healthspan and ALS Research: Moving forward, Dr. Daneshvar’s HealthSpan Lab is expanding this predictive model to track other catastrophic long-term outcomes, investigating how biological, environmental, and behavioral variables interact to trigger neurodegenerative diseases like Amyotrophic Lateral Sclerosis (ALS) post-injury.
Source: Mass General
By analyzing data from the Traumatic Brain Injury Model Systems National Database, Mass General Brigham researchers found that a history of traumatic brain injury was associated with increased risk of brain cancer mortality.
Daniel Daneshvar, MD, PhD, director of the HealthSpan Lab and Chief of the Department of Physical Medicine and Rehabilitation at Mass General Brigham, and Charlotte Luster, of the HealthSpan Lab, are the senior and lead authors of a paper published in Neuroepidemiology, “Brain Cancer Mortality following Traumatic Brain Injury (TBI): A TBI Model Systems Study.”
Q: What challenges or unmet needs make this study important?
Traumatic brain injury (TBI) affects millions of people each year, yet its long-term consequences, including potential links to brain cancer mortality, remain poorly understood. While some studies have suggested that moderate-to-severe TBI may increase the risk of brain tumors, no prior research has systematically examined whether TBI increases the risk of dying from brain cancer. Determining whether specific injury types carry heightened mortality risk is critical for informing follow-up care, counseling patients and families, and identifying survivors who may benefit most from monitoring.
Q: What central question(s) were you investigating?
This study examined whether individuals who sustain a TBI are more likely to die from brain cancer compared to the general population, and whether certain factors modify that risk. By focusing on mortality rather than incidence alone, our study addressed a key gap: even if TBI increases the likelihood of developing a brain tumor, it has been unclear whether it translates into worse survival outcomes at the population level.
Q: What methods or approach did you use?
We analyzed data from the TBI Model Systems National Database, a large, longitudinal cohort of more than 20,000 civilians with TBI who received inpatient rehabilitation across 20 centers—including Spaulding Rehabilitation Hospital—between 1987 and 2024. Brain cancer deaths were identified using death certificates. Our team compared observed deaths in the TBI cohort to expected deaths in a demographically matched general population, adjusting for age, sex, race and calendar year. Subgroup analyses assessed differences by injury severity (mild, moderate or severe), injury mechanism and cancer risk factors such as smoking and alcohol use.
Q: What did you find?
People with TBI were 1.75 times more likely to die from brain cancer than the general population. The elevated risk was particularly striking among those whose injuries resulted from gunshot wounds, who were over 14 times more likely to die from brain cancer. Individuals with mild but complicated TBI also had nearly four times the brain cancer mortality risk. Moderate-to-severe TBI showed elevated but statistically nonsignificant risk, likely due to smaller sample sizes.
Q: What are the real-world implications, particularly for patients?
These findings suggest that certain groups of TBI survivors may benefit from closer long-term monitoring for brain cancer. For clinicians, the results reinforce that TBI should not be viewed solely as an acute event, but as a condition with potential long-term neurological consequences, including malignancy. For patients and families, the study highlights the importance of ongoing follow-up care after serious brain injury.
More broadly, the findings add to growing evidence that inflammation triggered by TBI may have lasting biological effects. While not yet sufficient to change clinical guidelines, this work supports further research into cancer surveillance among TBI survivors and underscores the value of linking injury registries with cancer databases to better track long-term outcomes.
Q: Do you have any follow-up studies planned to validate or build on these findings?
We are continuing to investigate the long-term impacts of TBI across a range of outcomes, including neurodegenerative conditions such as amyotrophic lateral sclerosis (ALS). Building on these findings, our future work will explore how biological, behavioral and environmental factors interact to shape long-term risk after TBI. In particular, we aim to identify markers of resilience and vulnerability, as well as opportunities for early intervention to improve healthspan, the period of life spent in good health. A key focus will be identifying practical ways to reduce risk and improve long-term outcomes, with an emphasis on maintaining function and quality of life over time.
Authorship: In addition to Daneshvar and Luster, Mass General Brigham authors include Shanti Pinto, Mitra McLarney, Evan D Feigel, Saef Izzy, Brian Nahed and Joseph Giacino.
Paper cited: Luster, C.B., et al. “Brain Cancer Mortality following Traumatic Brain Injury (TBI): A TBI Model Systems Study.” Neuroepidemiology. DOI: 10.1159/000552405
Funding: This paper was supported by grants from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR): (90DPTB0027), 90DPTB0022) and (90DPTB0023).
Disclosures: Luster reports receiving clinical funding from the Brain and Body Program, funded by the NFLPA, outside the submitted work. Daneshvar reported receiving personal fees for providing expert testimony related to traumatic brain injury and spinal cord injury and serving as a medical advisor and options holder for StataDx outside the submitted work; receiving research funding from the Football Players Health Study at Harvard University (FPHS), funded by the NFL Players Association (NFLPA); serving as a volunteer member of the Mackey-White Committee of the NFLPA; and receiving clinical funding from the Brain and Body Program funded by the NFLPA, all outside the submitted work. A complete list of author disclosures can be found in the paper.
Key Questions Answered:
A: No, an increased risk of mortality does not mean brain cancer is guaranteed or even common among TBI survivors. The study found that across more than 20,000 patients tracked over decades, a history of TBI raises the overall likelihood of dying from brain cancer by 1.75 times compared to the general public. While this is a serious statistical jump that clinicians need to monitor, the actual baseline occurrence of brain cancer remains rare.
A: Researchers believe the connection is driven by chronic, long-term inflammation. When the brain sustains a serious physical trauma, especially high-impact or penetrating injuries like gunshot wounds, it triggers a massive cellular immune response. If this inflammatory healing process fails to shut down completely, it creates a permanently stressed, hyper-active biological environment that can eventually mutate cells and drive tumor growth.
A: They should work with their healthcare providers to establish long-term neurological follow-up care. Historically, TBIs have been treated as acute emergencies, once the wound heals or the initial rehabilitation ends, tracking stops. This Mass General Brigham study proves that head trauma has chronic, lifelong consequences. Survivors, particularly those with gunshot wounds or complicated head trauma, should ensure their doctors treat their TBI history as an active factor in their ongoing wellness and neurological screening.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full.
- Additional context added by our staff.
About this TBI and brain cancer research news
Author: Tim Sullivan
Source: Mass General Brigham
Contact: Tim Sullivan – Mass General Brigham
Image: The image is credited to Neuroscience News
Original Research: Open access.
“Brain Cancer Mortality following Traumatic Brain Injury (TBI): A TBI Model Systems Study” by Charlotte B. Luster, Shanti M. Pinto, Mitra D. McLarney, Evan D. Feigel, Bhaskar Thakur, Saef Izzy, Brain V. Nahed, Ross D. Zafonte, Flora M. Hammond, Joseph T. Giacino, and Daniel H. Daneshvar. Neuroepidemiology
DOI:10.1159/000552405
Abstract
Brain Cancer Mortality following Traumatic Brain Injury (TBI): A TBI Model Systems Study
Introduction: Growing evidence suggests traumatic brain injury (TBI) may be a risk factor for subsequent brain cancer. We aimed to compare brain cancer mortality rates between persons with TBI and the general population.
Methods: Retrospective cohort study of 20,211 individuals with TBI admitted for inpatient rehabilitation following acute hospitalization who enrolled in the TBI Model Systems (TBIMS) National Database (1987-2024). Brain cancer cases were identified by underlying or contributing cause of death on death certificate. Standardized mortality ratios (SMRs) compared to an age, sex, race, and calendar-year matched general population were calculated using the National Institute for Occupational Safety and Health LTASR R package. Secondary analyses explored brain cancer risk factors.
Results: Of the 4,297 decedents, 18 died of brain cancer, reflecting a higher rate than the general population (SMR=1.75; 95%CI:1.04-2.77). Significantly higher brain cancer mortality was observed among participants with gunshot wound (GSW) related TBI (SMR=14.29; 95%CI:2.95-41.75), mild TBI (mTBI; SMR=3.88; 95%CI:1.06-9.94), but not moderate-to-severe TBI (SMR=1.52; 95%CI:0.83-2.54).
Conclusion: Individuals who sustained a TBI had a 1.75-fold higher likelihood of brain cancer death than the general population. Further analyses observed increased brain cancer mortality risk among those with GSW-related TBI and mTBI. Together, these results may inform targets for early prevention and support further investigation of the causal pathophysiology underlying TBI-related brain cancer mortality.
